Modulators of G protein-activated inwardly rectifying K+ channels: potentially therapeutic agents for addictive drug users.
- Authors
- Kobayashi, Toru; Washiyama, Kazuo; Ikeda, Kazutaka
- Year
- 2004
- Journal
- Annals of the New York Academy of Sciences
- PMID
- 15542767
- DOI
- 10.1196/annals.1316.073
G protein-activated inwardly rectifying K+ (GIRK, Kir3) channels play an important role in the inhibitory regulation of neuronal excitability in most brain regions and heart rate through activation of various G protein-coupled receptors, such as opioid, cannabinoid, and D2 dopamine receptors. Therefore, modulators of GIRK channels may affect many brain functions. We have shown using Xenopus oocyte expression assays that ethanol directly activates GIRK channels, whereas various antipsychotics (thioridazine, clozapine, pimozide, and haloperidol) inhibit the channels. Here we investigated not only the effects of various selective serotonin reuptake inhibitor (SSRI) antidepressants (fluoxetine, citalopram, fluvoxamine, and zimelidine) and risperidone, an atypical antipsychotic, on GIRK channels, but also those of the various drugs tested on other Kir channels using the Xenopus oocyte system. Fluoxetine inhibited GIRK channels, whereas the other SSRIs and risperidone had a small or no effect on the channels. In contrast, Kir1.1 and Kir2.1 channels were insensitive to ethanol and various SSRIs and antipsychotics, although thioridazine weakly inhibited Kir1.1 channels. It has been shown that the function of GIRK channels is involved in seizure susceptibility, antinociception by opioids, cannabinoids, or ethanol, and cocaine reinforcement in studies using GIRK knockout mice and weaver mutant mice that have mutant GIRK2 channels insensitive to G proteins and ethanol. Activation of GIRK channels by opioids, cannabinoids, or ethanol may be one of these key effects. Therefore, GIRK channel modulators might be potential agents for the treatment of users of addictive drugs, such as cocaine, opioids, cannabinoids, and ethanol, as well as for the treatment of epilepsy and pain.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Heavy adolescent drinking makes the adult brain more vulnerable to ethanol by permanently altering the age-dependent interplay between alcohol, GIRK channels and activin. | Stürzenberger S et al. | — | 2026 | → |
| Second-generation antipsychotics - Cardiac ion channel modulation and QT interval disturbances: A review. | Erkan O et al. | — | 2025 | → |
| Inhibition of kidney potassium channels by fluoxetine: In vivo and in vitro studies. | Vieira-Coelho MA et al. | — | 2023 | → |
| Possible Interaction of Opioidergic and Nitrergic Pathways in the Anticonvulsant Effect of Ivermectin on Pentylenetetrazole-Induced Clonic Seizures in Mice. | Jourian S et al. | — | 2023 | → |
| The role of alcohol intake in the pharmacogenetics of treatment with clozapine. | Monroy-Jaramillo N et al. | — | 2022 | → |
| Advances in Targeting GIRK Channels in Disease. | Zhao Y et al. | — | 2021 | → |
| Clozapine, nimodipine and endosulfan differentially suppress behavioral defects caused by gain-of-function mutations in a two-pore domain K<sup>+</sup> channel (UNC-58). | Kasap M et al. | — | 2021 | → |
| Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products. | An D et al. | — | 2020 | → |
| A KCNJ6 gene polymorphism modulates theta oscillations during reward processing. | Kamarajan C et al. | — | 2017 | → |
| Inhibition of 17-beta-estradiol on neuronal excitability via enhancing GIRK1-mediated inwardly rectifying potassium currents and GIRK1 expression. | Zhang Y et al. | — | 2017 | → |
| Behavioral and Genetic Evidence for GIRK Channels in the CNS: Role in Physiology, Pathophysiology, and Drug Addiction. | Mayfield J et al. | — | 2015 | → |
| Kir6.2 is not the mitochondrial KATP channel but is required for cardioprotection by ischemic preconditioning. | Wojtovich AP et al. | — | 2013 | → |
| Physiological consequences of complex II inhibition for aging, disease, and the mKATP channel. | Wojtovich AP et al. | — | 2013 | → |
| Role of GIRK channels on the noradrenergic transmission in vivo: an electrophysiological and neurochemical study on GIRK2 mutant mice. | Torrecilla M et al. | — | 2013 | → |
| A step towards characterisation of electrophysiological profile of torsadogenic drugs. | Champeroux P et al. | — | 2011 | → |
| Identification of selective agonists and antagonists to g protein-activated inwardly rectifying potassium channels: candidate medicines for drug dependence and pain. | Nishizawa D et al. | — | 2011 | → |
| Naringin directly activates inwardly rectifying potassium channels at an overlapping binding site to tertiapin-Q. | Yow TT et al. | — | 2011 | → |
| A KCNJ6 (Kir3.2, GIRK2) gene polymorphism modulates opioid effects on analgesia and addiction but not on pupil size. | Lötsch J et al. | — | 2010 | → |
| Amphetamine up-regulates activator of G-protein signaling 1 mRNA and protein levels in rat frontal cortex: the role of dopamine and glucocorticoid receptors. | Schwendt M et al. | — | 2010 | → |
| A novel mitochondrial K(ATP) channel assay. | Wojtovich AP et al. | — | 2010 | → |
| Emerging roles for G protein-gated inwardly rectifying potassium (GIRK) channels in health and disease. | Lüscher C et al. | — | 2010 | → |
| Escitalopram causes fewer seizures in human overdose than citalopram. | Yilmaz Z et al. | — | 2010 | → |
| CRF enhancement of GIRK channel-mediated transmission in dopamine neurons. | Beckstead MJ et al. | — | 2009 | → |
| Inhibition of G protein-activated inwardly rectifying K+ channels by ifenprodil. | Kobayashi T et al. | — | 2006 | → |
| Inhibition of G protein-activated inwardly rectifying K+ channels by the antidepressant paroxetine. | Kobayashi T et al. | — | 2006 | → |
| Differential ion current activation by human 5-HT(1A) receptors in Xenopus oocytes: evidence for agonist-directed trafficking of receptor signalling. | Heusler P et al. | — | 2005 | → |
| Effect of natural and synthetic polyamines on ethanol intake in UChB drinker rats. | Bilbeny N et al. | — | 2005 | → |
| Ion channels and intracellular signaling proteins as potential targets for novel therapeutics for addictive and depressive disorders. | Bonci A et al. | — | 2005 | → |